StudyRareStudyRare
Log in to add personal notes on this page.

A child with short stature, absent thumbs, and café-au-lait spots develops progressive pancytopenia at age 7. Chromosome breakage testing with DEB is positive.

AR (most), X-linked (FANCB), or AD (RAD51); at least 23 genes. Loss-of-function variants disable the FA pathway, which lets cells resist DNA cross-linking agents.

  • FANCA most common (60%-70%)
  • FA pathway: DNA interstrand crosslink repair

The FA proteins work in one pathway that regulates cellular resistance to DNA cross-linking agents. Eight of them, with two associated proteins, form a nuclear ubiquitin ligase, the core complex. In response to DNA damage, the core complex monoubiquitinates the products of FANCD2 and FANCI, which then move to nuclear foci with the products of BRCA1, BRCA2, PALB2, and RAD51. The BRCA2, PALB2, and BRIP1 products are not needed for that step but are still required for resistance to mitomycin C and diepoxybutane. FA cells therefore show increased chromosome breakage with these agents, which is the diagnostic test.

Bone marrow fails because hematopoietic stem cells die by apoptosis in response to DNA damage they cannot resolve. Activation of p53 in that damage response protects against malignant change but speeds stem cell loss.

In general, null variants give a more severe picture (congenital anomalies, early marrow failure, MDS or AML) than hypomorphic ones. Specific BRCA2 intron 7 splice variants carry the greatest AML risk, with AML by age three years in every reported homozygote or compound heterozygote, and FANCB-related FA has the highest rate of congenital anomalies, with VACTERL-H in about 80% of males with truncating or null variants.

  • Physical abnormalities: Radial ray (thumb, radius), café-au-lait spots, short stature, microcephaly, renal anomalies
  • Hematologic: Progressive bone marrow failure (pancytopenia)
  • Cancer predisposition: MDS, AML, squamous cell carcinomas (head/neck, anogenital)
  • Chromosome breakage with DEB or MMC
  • Chromosome breakage testing with diepoxybutane (DEB) or mitomycin C (MMC) is the gold standard: excessive chromosomal breaks and radial figures confirm the diagnosis
  • CBC shows progressive pancytopenia; bone marrow evaluation assesses hypocellularity, MDS, and clonal cytogenetic changes
  • Molecular testing of the FA gene panel (including FANCA) confirms the complementation group and enables carrier and prenatal testing; somatic mosaicism can cause false-negative blood breakage tests, so fibroblast testing may be needed
  • HSCT (for marrow failure), cancer surveillance

Fanconi = Fingers (missing thumb): Imagine a fan shredding the entire bone marrow and thumbs. Radial ray anomalies (absent thumbs/radii) are a hallmark.

"Fanboni" anemia has bone marrow failure: First comes thrombocytopenia, then neutropenia, then anemia (pancytopenia). Distinguish from Diamond-Blackfan anemia (RBC aplasia only).

AR cancer genes causing Fanconi: Biallelic (AR) variants in BRCA2, BRIP1, PALB2, or RAD51C cause Fanconi anemia, while heterozygous (AD) variants in these same genes cause cancer predisposition.